GlassScriptPhysician profile
Stephen D Moyer
NPI 1003896036
$2,575.29
in general payments reported to CMS, 2019-2025
17 companies · $555 in 2025
The $555 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $229 · 2021: $476 · 2022: $623 · 2023: $62.81 · 2024: $223 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.40 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $554.29 | 2019-2025 | Tremfya |
| Abbvie INC. | $496.54 | 2019-2025 | |
| Leo Pharma INC. | $439.77 | 2019-2025 | Anzupgo |
| Novartis Pharmaceuticals Corporation | $246.43 | 2019-2023 | |
| Dermavant Sciences, INC. | $207.28 | 2023-2024 | Vtama |
| Allergan, INC. | $113.56 | 2021-2022 | |
| Ucb, INC. | $102.86 | 2019-2024 | Bimzelx |
| Organon LLC | $91.21 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $62.34 | 2024-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $55.24 | 2019-2025 | Aklief |
| Amgen INC. | $49.00 | 2022-2025 | Otezla |
| Pfizer INC. | $33.56 | 2021-2022 | |
| Almirall LLC | $29.98 | 2019 | |
| Vyne Pharmaceuticals INC. | $27.49 | 2021 | |
| Celgene Corporation | $24.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $22.21 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Moyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.